Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 138

Showing 26-50 of 138 citing articles:

Radiotherapy‐Associated Cellular Senescence and EMT Alterations Contribute to Distinct Disease Relapse Patterns in Locally Advanced Cervical Cancer
Lei Zhang, Jun Ma, Jun Zhang, et al.
Advanced Science (2025)
Open Access
Usp11 maintained the survival of marginal zone B cells under ionizing radiation by deubiquitinating DLL1 and JAG2
Jiaqi Sheng, Depei Wu, Jingzhe Shang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Genetically Engineered Magnesium/Manganese Nanoparticles for Cancer Radioimmunotherapy
Jicheng Wu, Yangtao Xu, Yunjing Zhang, et al.
(2025)
Closed Access
Microneedle-based nanodrugs for tumor immunotherapy
Tianye Wang, Hongyu Liu, Meng Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 539-562
Closed Access
Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 18
Deposition of onco‐histone H3.3‐G34W leads to DNA repair deficiency and activates cGAS/STING‐mediated immune responses
Daniela Mancarella, Henrik Ellinghaus, Gianluca Sigismondo, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 12, pp. 2106-2120
Open Access | Times Cited: 5
Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions
Nicholas Colangelo, Naamit K. Gerber, Ralph E. Vatner, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Nanotechnology-based in situ cancer vaccines: Mechanisms, design, and recent advances
Gaoli Niu, Hong Wang, Yanhong Zhai, et al.
Nano Today (2024) Vol. 56, pp. 102286-102286
Closed Access | Times Cited: 5
Radiotherapy-sensitized cancer immunotherapy via cGAS-STING immune pathway by activatable nanocascade reaction
Honglei Hu, Shuting Zheng, Chenxi He, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 5
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Zhaoyou Chu, Wanni Wang, Zheng Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 17, pp. 8847-8877
Closed Access | Times Cited: 5
Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders
Pui Lam Yip, Rui You, Ming‐Yuan Chen, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 383-383
Open Access | Times Cited: 4
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 4
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
Hui Wang, Zhuoran Yao, Kai Kang, et al.
Med (2024) Vol. 5, Iss. 10, pp. 1237-1254.e9
Open Access | Times Cited: 4
Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology
Vijay Kumar, Caitlin Bauer, John H. Stewart
European Journal of Cell Biology (2023) Vol. 102, Iss. 3, pp. 151338-151338
Open Access | Times Cited: 13
Radiation therapy with phenotypic medicine: towards N-of-1 personalization
Li Ming Chong, Peter Wang, V Vien Lee, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 1, pp. 1-10
Closed Access | Times Cited: 4
The interplay between autophagy and cGAS-STING signaling and its implications for cancer
Maximilian Schmid, Patrick D. Fischer, Magdalena Engl, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial
Ming-Ming He, Zhiqiang Wang, Jin Lu, et al.
Med (2024) Vol. 5, Iss. 9, pp. 1137-1149.e3
Closed Access | Times Cited: 4
Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?
Lin Ma, Liufu Deng, Jianfeng Peng, et al.
Cancer Biology and Medicine (2024) Vol. 20, Iss. 12, pp. 1035-1046
Open Access | Times Cited: 3
Enhancing X‐Ray Sensitization with Multifunctional Nanoparticles
Jiayi Liu, Junyong Wu, Taili Chen, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 3
A machine learning radiomics based on enhanced computed tomography to predict neoadjuvant immunotherapy for resectable esophageal squamous cell carcinoma
Jialing Wang, Liansha Tang, Xia Zhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Tumor Microenvironment Reprogrammed Bimetallic Hybrid Nanostimulator for Triggering Radio‐Cuproptosis‐Immunotherapy
Xiaohong Jiang, Jin Wang, Weijie Huang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 30
Open Access | Times Cited: 3
Radiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
Jean‐Pierre Pouget, Timothy A. Chan, Lorenzo Galluzzi, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 968-981
Open Access | Times Cited: 10
ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I
Chunya Li, Boyu Wang, Jingyao Tu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 3
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial
Jian Zhang, Minghao Li, Kaixian Zhang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1173-1188
Open Access | Times Cited: 3

Scroll to top